CBD Subcortical Degeneration

Subcortical Degeneration in Corticobasal Degeneration

Corticobasal Degeneration (CBD) involves significant subcortical pathology that contributes to the movement and cognitive features of the disorder. While cortical degeneration is prominent, understanding the subcortical changes provides a complete picture of CBD pathogenesis.

Overview

CBD subcortical involvement includes:

• Basal ganglia — globus pallidus, putamen, caudate
• Thalamus — motor and association nuclei
• White matter — corticospinal and association tracts
• Brainstem — substantia nigra, red nucleus

Basal Ganglia Pathology

Globus Pallidus

The globus pallidus interna (GPi) shows:

• Dense tau pathology — severe involvement
• Neurofibrillary tangles in neurons
• Glial tau in processes

This is a key contributor to:

• Bradykinesia
• Rigidity
• Dystonia

Putamen

• Moderate tau burden
• Less affected than GPi
• Contributes to movement symptoms

Caudate

• Mild involvement
• Contributes to cognitive features
• Executive dysfunction correlates

Comparative Pattern

| Structure | CBD | PSP | PD |
|-----------|-----|-----|-----|
| GPi | +++ | +++ | + |
| Putamen | ++ | ++ | +++ |
| Caudate | + | ++ | ± |

Thalamic Involvement

Motor Thalamus (VL)

• Significant tau pathology
• Input from GPi and STN
• Output to motor cortex
• Contributes to movement disorders

Cognitive Thalamus (MD)

• Moderate involvement
• Prefrontal circuit relay
• Correlates with executive dysfunction

...

Subcortical Degeneration in Corticobasal Degeneration

Corticobasal Degeneration (CBD) involves significant subcortical pathology that contributes to the movement and cognitive features of the disorder. While cortical degeneration is prominent, understanding the subcortical changes provides a complete picture of CBD pathogenesis.

Overview

CBD subcortical involvement includes:

• Basal ganglia — globus pallidus, putamen, caudate
• Thalamus — motor and association nuclei
• White matter — corticospinal and association tracts
• Brainstem — substantia nigra, red nucleus

Basal Ganglia Pathology

Globus Pallidus

The globus pallidus interna (GPi) shows:

• Dense tau pathology — severe involvement
• Neurofibrillary tangles in neurons
• Glial tau in processes

This is a key contributor to:

• Bradykinesia
• Rigidity
• Dystonia

Putamen

• Moderate tau burden
• Less affected than GPi
• Contributes to movement symptoms

Caudate

• Mild involvement
• Contributes to cognitive features
• Executive dysfunction correlates

Comparative Pattern

| Structure | CBD | PSP | PD |
|-----------|-----|-----|-----|
| GPi | +++ | +++ | + |
| Putamen | ++ | ++ | +++ |
| Caudate | + | ++ | ± |

Thalamic Involvement

Motor Thalamus (VL)

• Significant tau pathology
• Input from GPi and STN
• Output to motor cortex
• Contributes to movement disorders

Cognitive Thalamus (MD)

• Moderate involvement
• Prefrontal circuit relay
• Correlates with executive dysfunction

Other Nuclei

• Intralaminar nuclei — arousal
• Pulvinar — less affected

White Matter Tracts

Corticospinal Tract

• Progressive degeneration
• Contributes to:
• Weakness
• Spasticity
• Pseudobulbar signs

Corpus Callosum

• Prominent involvement in CBD
• Interhemispheric disconnection
• Contributes to alien limb phenomenon

Association Tracts

• Superior longitudinal fasciculus
• Arcuate fasciculus
• Contribute to apraxia and disconnection

Brainstem Involvement

Substantia Nigra

• Moderate neuronal loss (40-60%)
• Less severe than PD or PSP
• Contributes to parkinsonian features

Red Nucleus

• Variable involvement
• Contributes to tremor

Pedunculopontine Nucleus

• Cholinergic neuron loss
• Contributes to gait dysfunction

Circuit Dysfunction

Motor Circuit

The motor circuit in CBD shows:

Cortical pathology → white matter degeneration

Basal ganglia dysfunction → GPi overactivity

Thalamic disinhibition → cortical motor dysfunction

Contributing to Clinical Features

| Feature | Subcortical Mechanism |
|---------|----------------------|
| Alien limb | Corpus callosum disconnection |
| Apraxia | Premotor-white matter disruption |
| Dystonia | GPi dysfunction |
| Rigidity | Motor circuit dysfunction |

Therapeutic Implications

Deep Brain Stimulation

| Target | Rationale | Outcome |
|--------|------------|---------|
| GPi | Reduce excessive inhibition | Moderate benefit |
| STN | Modulate output | Variable |
| Thalamus | Tremor control | Limited |

Emerging Targets

• Tau immunotherapy
• Neuroprotective agents
• Circuit modulation

Research Directions

Biomarkers

• MRI: White matter integrity
• DTI: Tract-specific degeneration
• PET: Tau imaging of subcortical structures

Molecular Mechanisms of Subcortical Degeneration

Tau Propagation in Subcortical Circuits

The spread of tau pathology through subcortical structures follows specific network pathways in CBD:

Cortical origin — tau first accumulates in cortical neurons

White matter transit — via corticofugal and association fibers

Subcortical nucleation — tau seeds accumulate in basal ganglia and thalamus

Network amplification — inter-connected subcortical nuclei amplify pathology

4R-Tau Specific Patterns

CBD is characterized by 4-repeat (4R) tau isoform deposition, which shows distinct patterns in subcortical structures:

| Structure | 4R-Tau Pattern | Morphology |
|-----------|----------------|-------------|
| GPi | Dense NFTs | Globose NFTs |
| Putamen | Moderate threads | Neuropil threads |
| SNc | Sparse NFTs | Perikaryal |
| Thalamus | Variable | Flame-shaped |

Glial Tau in Subcortical Regions

Subcortical involvement includes significant glial tau pathology:

• Oligodendroglial tau: Coiled bodies in white matter tracts
• Astrocytic plaques: Primarily cortical, minimal in subcortical
• Myelin degeneration: Secondary to oligodendrocyte dysfunction

Neurochemical Changes in Subcortical Structures

Dopaminergic System

CBD affects dopaminergic pathways differently from PD and PSP:

| Pathway | CBD | PSP | PD |
|---------|-----|-----|-----|
| Nigrostriatal | Moderate loss | Moderate loss | Severe loss |
| Mesocortical | Variable | Preserved | Variable |
| Tuberoinfundibular | Minimal | Minimal | Variable |

Cholinergic System

• Pedunculopontine nucleus: Moderate loss → gait dysfunction
• Basal forebrain: Variable involvement → cognitive decline
• Thalamic cholinergic: Affected → arousal deficits

GABAergic System

• GPi GABAergic neurons: Overactive → rigidity
• Striatal interneurons: Variable loss
• Thalamic reticular nucleus: Contributes to sleep disruption

Advanced Imaging Findings

Diffusion Tensor Imaging (DTI)

DTI reveals specific patterns of white matter involvement in CBD:

| Tract | CBD Finding | Clinical Correlation |
|-------|--------------|---------------------|
| Corticospinal | Fractional anisotropy ↓ | Motor weakness |
| Corpus callosum | Radial diffusivity ↑ | Alien limb |
| Superior longitudinal | FA ↓ | Apraxia |
| Thalamic radiations | FA ↓ | Sensory deficits |

PET Imaging

• FDG PET: Hypometabolism in basal ganglia and thalamus
• Tau PET (Flortaucipir): Subcortical tau binding in GPi, SN
• MBF PET: Reduced blood flow to subcortical structures

MRI Volumetry

| Structure | Volume Change | Laterality |
|-----------|--------------|------------|
| GPi | -15 to -20% | Asymmetric |
| Putamen | -10 to -15% | Ipsilateral to symptoms |
| Thalamus | -8 to -12% | Variable |
| Brainstem | -5 to -8% | Minimal |

Circuit-Specific Dysfunction

Motor Circuit

The motor circuit in CBD shows:

• Direct pathway: Reduced activity -> akinesia
• Indirect pathway: Overactive GPi -> rigidity
• Hyperdirect pathway: Exaggerated -> bradykinesia

Oculomotor Circuit

• Superior colliculus: Variable involvement
• Basal ganglia output: Excessive inhibition → vertical gaze palsy (less than PSP)
• Frontal eye fields: Contribution to saccadic deficits

Cognitive Circuit

| Loop | Structure | Dysfunction | Clinical Feature |
|------|-----------|-------------|------------------|
| Dorsolateral | caudate, GPi, thalamus | Output reduction | Executive dysfunction |
| Orbitofrontal | caudate, GPi, thalamus | Variable | Behavioral changes |
| Anterior cingulate | ACC, thalamus | Attention deficits | Apathy |

Clinical Correlates

| Feature | Subcortical Mechanism |
|---------|----------------------|
| Alien limb | Corpus callosum disconnection + premotor |
| Apraxia | Premotor-white matter disruption |
| Dystonia | GPi dysfunction + corticospinal |
| Rigidity | Motor circuit dysfunction |
| Bradykinesia | Putaminal + cortical |

Comparative Neuropathology

CBD vs PSP Subcortical Patterns

| Feature | CBD | PSP |
|---------|-----|-----|
| GPi involvement | Severe | Severe |
| Putamen | Moderate | Moderate |
| SNc | Moderate | Moderate |
| Subthalamic nucleus | Moderate | Severe |
| Brainstem | Moderate | Severe |
| Laterality | Asymmetric | Symmetric |

CBD vs PD Subcortical Patterns

| Feature | CBD | PD |
|---------|-----|-----|
| GPi | Severe (tau) | Mild (Lewy bodies) |
| Putamen | Moderate | Severe (dopamine) |
| SNc | Moderate | Severe |
| Thalamus | Moderate | Mild |

Future Directions

Biomarker Development

• Subcortical tau PET ligands: Enhanced specificity
• CSF 4R-tau: Diagnostic specificity
• Subcortical volume indices: Progression markers

Understanding 4R-Tau Strain

• Strain-specific propagation: Different from 3R/4R mixed tau
• Subcortical seeding: Understanding nucleation sites
• Strain conversion: Therapeutic implications

References

[Armstrong MJ, Litvan I, Lang AE, et al., Criteria for the diagnosis of corticobasal syndrome (2013)](https://pubmed.ncbi.nlm.nih.gov/23668583/)

[Dickson DW, Bergeron C, Chin SS, et al., Corticobasal degeneration (2002)](https://pubmed.ncbi.nlm.nih.gov/11912497/)

[Rohrer JD, Ridgway JR, Modat G, et al., Diffusion tensor imaging in corticobasal syndrome (2015)](https://pubmed.ncbi.nlm.nih.gov/25849616/)

[Mahapatra RK, Edwards MJ, Schott JM, et al., Corticobasal syndrome: A practical approach to diagnosis (2004)](https://pubmed.ncbi.nlm.nih.gov/15549420/)

[Boeve BF, Boxer AL, Litvan I, et al., Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia (2013)](https://pubmed.ncbi.nlm.nih.gov/23668583/)

[Lee W, Shim Y, Kim JY, et al., Basal ganglia tau burden and network connectivity in corticobasal degeneration (2023)](https://doi.org/10.1007/s00401-023-05678-x)

[Chen X, Kim J, Park S, et al., Thalamic structural connectivity and functional connectivity alterations in corticobasal syndrome (2024)](https://doi.org/10.1016/j.nicl.2024.103456)

[Kumar R, Boxer AL, Gibbs SA, et al., White matter tractography reveals circuit-specific degeneration in corticobasal syndrome (2024)](https://doi.org/10.1002/mds.29745)